We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CRF Health Enhances TrialManager for Intelligent eCOA Reporting & Data Visualization

Product News   May 31, 2016

 
CRF Health Enhances TrialManager for Intelligent eCOA Reporting & Data Visualization
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 Initiates in Taiwan

Product News

The first volunteers have been safely dosed in COVAXX's Phase 1, open-label, dose-escalation study of the UB-612 vaccine candidate for COVID-19 in Taiwan.

READ MORE

First Data on Using a Therapeutic Form of ACE2 To Treat COVID-19 Published

Product News

A case report published today in The Lancet Respiratory Medicine outlines the first compassionate use of recombinant soluble human ACE2 (APN01) to treat a female 45-year-old patient who was diagnosed with severe COVID-19.

READ MORE

Phase III Trial of Janssen's COVID-19 Vaccine Launched

Product News

Johnson & Johnson today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE